Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitafloxacin versus doxycycline followed by moxifloxacin for Mycoplasma genitalium infection
jRCTs031230111Recruiting
- Sponsor
- National Center for Global Health and Medicine
- Start
- Aug 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in Mycoplasma genitalium infection (Mgen) comparing Sitafloxacin arm with Doxycycline followed by moxifloxacin arm (2 arms). Primary endpoint: Cure rate. Started Aug 2023; status: recruiting.
02
Drugs
sitafloxacinmoxifloxacindoxycycline
03
Conditions
Mycoplasma genitalium infection (Mgen)
Beyond the preview
Go deeper on jRCTs031230111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230111.